Spots Global Cancer Trial Database for CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Official Title: Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Homogenous Dose Distribution
Study ID: NCT00643994
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer.
Detailed Description: The CyberKnife Robotic Radiosurgery System is a unique radiosurgical system capable of treating tumors anywhere in the body noninvasively and with sub-millimeter accuracy. The CyberKnife System delivers radiation using a precise targeting methodology allowing a focal treatment margin around the target, thus limiting the volume of adjacent tissue receiving high doses radiation. This in turn allows the delivery of high doses of radiation to the prostate over a short series of treatments.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Scripps Cancer Center - CyberKnife of Southern California at Vista, La Jolla, California, United States
The CyberKnife at Newport Diagnostic Center, Newport Beach, California, United States
Georgetown University, Washington, District of Columbia, United States
Coastal CyberKnife and Radiation Oncology, Fort Pierce, Florida, United States
Jupiter Medical Center & CyberKnife Center of Palm Beach, Jupiter, Florida, United States
Northwest Community Hospital, Arlington Heights, Illinois, United States
Community Cancer Center, Normal, Illinois, United States
Central Baptist Hospital, Lexington, Kentucky, United States
Sinai Hospital of Baltimore, Baltimore, Maryland, United States
Franklin Square Hospital Center, Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
St. Joseph Mercy Hospital, Ann Arbor, Michigan, United States
Lake Saint Louis Oncology, Saint Louis, Missouri, United States
Saint Louis University, Saint Louis, Missouri, United States
St. Mary's Regional Medical Center, Reno, Nevada, United States
Capital Health, Trenton, New Jersey, United States
Hematology Oncology Associates of Central New York, Syracuse, New York, United States
Virginia Hospital Center, Arlington, Virginia, United States
Swedish Cancer Center, Seattle, Washington, United States
Southwest Washington Medical Center, Vancouver, Washington, United States
Southwest Washington Regional Cancer Center, Vancouver, Washington, United States
ThedaCare Appleton Medical Center, Appleton, Wisconsin, United States
Contact Details
Name: Robert Meier, MD
Affiliation: Swedish Cancer Center
Role: STUDY_CHAIR
Name: Irving Kaplan, MD
Affiliation: Beth Israel Deaconess Medical Center
Role: STUDY_CHAIR
Name: Martin Sanda, MD
Affiliation: Beth Israel Deaconess Medical Center
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
